BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
Часто задаваемые вопросы
В каком секторе работает BioHarvest Sciences Inc. Common Stock (BHST)?
BioHarvest Sciences Inc. Common Stock относится к сектору Товары повседневного спроса.
Какова текущая цена акций BioHarvest Sciences Inc. Common Stock (BHST)?
По последним данным, цена акций BioHarvest Sciences Inc. Common Stock составляет 1,70 $, предыдущее закрытие — 1,75 $. За последнюю торговую сессию акции BioHarvest Sciences Inc. Common Stock снизились на -0,05 $, что соответствует падению на -2,58%.
Выплачивает ли BioHarvest Sciences Inc. Common Stock (BHST) дивиденды?
Нет, BioHarvest Sciences Inc. Common Stock не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у BioHarvest Sciences Inc. Common Stock (BHST)?
У компании BioHarvest Sciences Inc. Common Stock бета 1.370, что указывает на повышенную волатильность по сравнению с рынком.